Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

361 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumors using biomarkers or the ROMA algorithm.
Kaijser J, Van Gorp T, Sayasneh A, Vergote I, Bourne T, Van Calster B, Timmerman D. Kaijser J, et al. Among authors: bourne t. Gynecol Oncol. 2013 Aug;130(2):398-9. doi: 10.1016/j.ygyno.2013.04.472. Epub 2013 May 6. Gynecol Oncol. 2013. PMID: 23656998 No abstract available.
Use of family history in a screening clinic for familial ovarian cancer.
Houlston R, Bourne TH, Davies A, Whitehead MI, Campbell S, Collins WP, Slack J. Houlston R, et al. Among authors: bourne th. Gynecol Oncol. 1992 Nov;47(2):247-52. doi: 10.1016/0090-8258(92)90114-x. Gynecol Oncol. 1992. PMID: 1468703
Ultrasound screening for familial ovarian cancer.
Bourne TH, Whitehead MI, Campbell S, Royston P, Bhan V, Collins WP. Bourne TH, et al. Gynecol Oncol. 1991 Nov;43(2):92-7. doi: 10.1016/0090-8258(91)90051-6. Gynecol Oncol. 1991. PMID: 1743564
Can ovarian masses be characterized using ultrasound?
Bourne T. Bourne T. Gynecol Oncol. 1993 Oct;51(1):4-6. doi: 10.1006/gyno.1993.1237. Gynecol Oncol. 1993. PMID: 8244173 No abstract available.
Re: Mol et al. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models. Gynecol Oncol 2001;80:162-7.
Timmerman D, Verrelst H, Collins WP, Bourne TH, Vergote I. Timmerman D, et al. Among authors: bourne th. Gynecol Oncol. 2001 Oct;83(1):166-8. doi: 10.1006/gyno.2001.6317. Gynecol Oncol. 2001. PMID: 11585433 No abstract available.
Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.
Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, Van Calster B, Collins WP, Vergote I, Van Huffel S, Valentin L; International Ovarian Tumor Analysis Group. Timmerman D, et al. Among authors: bourne t. J Clin Oncol. 2005 Dec 1;23(34):8794-801. doi: 10.1200/JCO.2005.01.7632. J Clin Oncol. 2005. PMID: 16314639 Clinical Trial.
Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors.
Timmerman D, Van Calster B, Jurkovic D, Valentin L, Testa AC, Bernard JP, Van Holsbeke C, Van Huffel S, Vergote I, Bourne T. Timmerman D, et al. Among authors: bourne t. J Clin Oncol. 2007 Sep 20;25(27):4194-200. doi: 10.1200/JCO.2006.09.5943. Epub 2007 Aug 13. J Clin Oncol. 2007. PMID: 17698805 Clinical Trial.
Preoperative identification of a suspicious adnexal mass.
Kaijser J, Sayasneh A, Van Calster B, Timmerman D, Bourne T. Kaijser J, et al. Among authors: bourne t. Gynecol Oncol. 2012 Oct;127(1):260-2. doi: 10.1016/j.ygyno.2012.07.099. Epub 2012 Jul 20. Gynecol Oncol. 2012. PMID: 22819788 No abstract available.
A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.
Kaijser J, Van Gorp T, Van Hoorde K, Van Holsbeke C, Sayasneh A, Vergote I, Bourne T, Timmerman D, Van Calster B. Kaijser J, et al. Among authors: bourne t. Gynecol Oncol. 2013 May;129(2):377-83. doi: 10.1016/j.ygyno.2013.01.018. Epub 2013 Jan 27. Gynecol Oncol. 2013. PMID: 23360924
361 results
Jump to page
Feedback